| USD millions | FY2019 | FY2020 | FY2021 | FY2022 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 0.3 | 0.3 | 0.4 | 0.3 | 1.2 | 1.5 | +25.6% | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 | 0.0 | −100.0% | |
| Operating expenses | 0.8 | 1.1 | 1.3 | 1.1 | 1.0 | 1.5 | +58.3% | |
| Operating income | 0.0 | (1.1) | (0.9) | (0.3) | (1.2) | (1.5) | −25.6% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 2.5 | 0.0 | 0.0 | −100.0% | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | −99.5% | |
| Other income / expense | (1.5) | 0.3 | (0.7) | (2.2) | 0.1 | 0.1 | −49.3% | |
| Pre-tax income | (1.5) | (0.7) | (1.8) | (2.5) | (1.1) | (1.5) | −34.8% | |
| Income tax | 1.5 | (0.3) | 0.9 | 2.5 | 0.0 | 0.0 | — | |
| Net income | (3.0) | (0.4) | (2.7) | (5.0) | (1.1) | (1.5) | −34.8% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (0.03) | (0.00) | (0.01) | (0.02) | (0.00) | (0.00) | −24.0% | |
| EPS, diluted (per share) | (0.03) | (0.00) | (0.01) | (0.02) | (0.00) | (0.00) | −24.0% | |
| EBITDA | 0.0 | (1.1) | (0.9) | (0.1) | (0.8) | (1.5) | −86.6% | |
| Depreciation & amortization | 0.2 | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 | — | |
| Weighted average shares (shares) | 96,953,000 | 175,680,000 | 231,393,000 | 289,557,000 | 436,279,000 | 477,237,000 | +9.4% | |
| Weighted average diluted shares (shares) | 96,953,000 | 175,680,000 | 231,393,000 | 289,557,000 | 436,279,000 | 477,237,000 | +9.4% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
Statements are reported in USD; the shares trade in GBP.
